Continuous Versus Conventional Volume Management During CRRT (Continuous Renal Replacement Therapy)
Not Applicable
Completed
- Conditions
- Continuous Renal Replacement Therapy
- Interventions
- Device: use of continuous renal replacement machine for renal replacementDevice: use of blood volume monitoring device in conjunction with machine used for continuous renal replacement to assess and determine volume removal
- Registration Number
- NCT01405092
- Lead Sponsor
- Dallas VA Medical Center
- Brief Summary
Use of on-line blood volume monitoring during continuous renal replacement therapy can improve volume management in acute kidney injury patients requiring renal replacement
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 28
Inclusion Criteria
- Patients with kidney injury requiring continuous renal replacement therapy and volume removal
Exclusion Criteria
- unable to provide or obtain patient consent
- not expected to survive 48 hours
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description Standard volume management use of continuous renal replacement machine for renal replacement patients on this arm will receive usual care volume management during continuous renal replacement therapy continuous volume management use of continuous renal replacement machine for renal replacement use of Critline, Hemametrics USA, in conjunction with continuous renal replacment therapy to determine volume removal continuous volume management use of blood volume monitoring device in conjunction with machine used for continuous renal replacement to assess and determine volume removal use of Critline, Hemametrics USA, in conjunction with continuous renal replacment therapy to determine volume removal
- Primary Outcome Measures
Name Time Method compare number of hypotensive events in treatment versus control arms 24 hour for each arm compare the number of hypotensive events during use of crit-line monitor over 24 hour period versus during control 24 hour period
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Dallas VA Medical Center
🇺🇸Dallas, Texas, United States